Part 5 of the series: Beyond Vitamin D: The Hidden Lifesaving Benefits of Sunlight
- Part 1: Sunlight Paradox: Why Sun Exposure Increases Cancer but Extends Life
- Part 2: How Sunlight Lowers CVD Mortality Through Nitric Oxide Release
- Part 3: Eat Your Greens, Then Get Some Sun: Boost Nitric Oxide and Lower Blood Pressure
- Part 4: Sunlight Reduces Diabetes and Metabolic Syndrome Risk, Studies Show
🎧 ▶️ Press the play button below to listen.
Introduction
The sun causes skin cancer. That much is settled.
We established it in Article 1. The Swedish study quantified it: basal cell carcinoma up 2.7-fold, squamous cell carcinoma up 2.3-fold, melanoma up 2.0-fold. The hazard ratios are real, the DNA damage is measurable, and the warning labels on sunscreen bottles are not fraudulent.
But here is the ultimate paradox — the one that forces us to rethink everything we thought we knew about sunlight and malignancy.
The same sun that causes skin cancer appears to protect against some of the most lethal internal cancers known to medicine.
Colon cancer. Breast cancer. Prostate cancer. Non-Hodgkin lymphoma. Together, these four malignancies kill more people in a single year than melanoma has killed in the past fifty years.
They are common, they are aggressive, and the evidence that sun exposure reduces their incidence — and improves survival when they do occur — is no longer fringe.
This is not a claim that sunlight “cures cancer.” It is a careful, evidence-based argument that the risk-benefit calculus around sun exposure has been dangerously incomplete.
The sun is not simply a carcinogen. It is a complex, full-spectrum physiological signal that regulates cell growth, differentiation, and immune surveillance throughout the body.
If you avoid the sun to prevent skin cancer, you may be trading a small, manageable risk for a far larger one.
The Mechanism: Why Sunlight Reaches Inside the Body
Before examining each cancer, it is worth understanding how sunlight — which barely penetrates beyond the skin’s surface — could possibly influence tumors deep inside the body.
The answer lies primarily in vitamin D, but not in the way most people think.
When UVB light hits the skin, it converts 7-dehydrocholesterol into previtamin D3, which becomes vitamin D3, which travels to the liver and then the kidneys, where it is converted into calcitriol — the active, hormonal form of vitamin D.
Calcitriol is not a vitamin in the classic sense. It is a steroid hormone. And its receptor — the vitamin D receptor (VDR) — is expressed in virtually every tissue in the human body, including:
- The epithelial cells lining the colon
- The ductal cells of the breast
- The glandular cells of the prostate
- The lymphocytes patrolling the lymphatic system
When calcitriol binds to the VDR in these tissues, it regulates the expression of hundreds of genes. Specifically, in the context of cancer, it:
- Promotes cellular differentiation — keeping cells specialized, organized, and functional rather than primitive and proliferative. Primitive cells tend to be precancerous.
- Inhibits proliferation — slowing down the uncontrolled cell division that defines malignancy
- Induces apoptosis — triggering programmed cell death in cells that have accumulated DNA damage
- Inhibits angiogenesis — preventing tumors from building the new blood vessels they need to grow beyond a few millimeters
- Reduces invasion and metastasis — hindering a tumor’s ability to degrade surrounding tissue and spread to distant sites
These are not minor, marginal effects. They strike at the fundamental hallmarks of cancer. A cell that is well differentiated, divides slowly, dies when damaged, and cannot recruit a blood supply simply cannot become a clinically significant tumor.
Calcitriol is, in a very real sense, the body’s endogenous physiological cancer-surveillance hormone. And its production begins with a photon of UVB light hitting the skin.
This does not mean vitamin D pills are equivalent to sun exposure — the bioavailability, the binding proteins, and the co-factors produced in sun-exposed skin all differ. But it does mean that a population systematically avoiding the sun has lower calcitriol production and, therefore, lower activation of this cancer-protective pathway in tissues throughout the body.
Colon Cancer: The Strongest Inverse Association
The link between sunlight and colon cancer is the most robust, most replicated, and least controversial among the cancers discussed here.
The Garland Hypothesis
In 1980, epidemiologists Dr. Frank Garland and Dr. Cedric Garland published a paper in the International Journal of Epidemiology that proposed something radical. They had noticed that colon cancer mortality rates in the United States showed a striking latitude gradient: the further north you lived, the more likely you were to die of colon cancer. [1]
Their hypothesis: sunlight exposure, through vitamin D production, protected against colon cancer.
At the time, it was considered speculative. Forty years later, it is considered prescient.
The Epidemiological Evidence
Multiple large prospective cohort studies have confirmed the association:
- A 2006 analysis of the Health Professionals Follow-Up Study found that men with the highest predicted vitamin D levels had a 40% lower risk of colon cancer compared to those with the lowest. [4]
- A 2018 pooled analysis of 17 cohorts, published in the Journal of the National Cancer Institute, found that higher circulating 25-hydroxyvitamin D levels were associated with a significantly lower colorectal cancer risk, particularly in women. [4]
- Studies using a personal history of non-melanoma skin cancer as a proxy for sun exposure consistently find a lower subsequent risk of colon cancer.
The effect size is not trivial. A 40% risk reduction for one of the most common and lethal cancers — achievable through a free, natural exposure — is extraordinary by any standard of preventive medicine.
The Mechanism in the Colon
Colon epithelial cells express the vitamin D receptor and the enzyme that converts circulating 25-hydroxyvitamin D into active calcitriol locally. This means the colon can regulate its own vitamin D activity without relying entirely on the kidneys.
When calcitriol binds to colon cells, it:
- Suppresses the Wnt/β-catenin signaling pathway, which is hyperactivated in the vast majority of colorectal cancers
- Promotes E-cadherin expression, keeping cells anchored to their neighbors and preventing the epithelial-to-mesenchymal transition that precedes metastasis
- Reduces inflammation, a known driver of colorectal carcinogenesis
The colon is, in evolutionary terms, the organ that evolved to receive the most consistent internal exposure to vitamin D, because our ancestors lived outdoors near the equator and produced vitamin D year-round.
It may be the organ most sensitive to the modern, indoor, vitamin D-deficient state.
Breast Cancer: The Second Pillar
Breast cancer is the most common cancer in women worldwide. The link with sunlight is nearly as strong as for colon cancer, but it carries additional nuance.
The Epidemiological Evidence
A 2014 meta-analysis published in the American Journal of Clinical Nutrition pooled data from observational studies and found that women with the highest serum 25-hydroxyvitamin D levels had a 50% lower risk of developing breast cancer compared to those with the lowest. [2]
Other key studies:
- The Nurses’ Health Study found that higher vitamin D levels were associated with lower breast cancer risk, particularly for postmenopausal breast cancer. [6]
- A 2011 study in Cancer Causes and Control found that women with the highest sun exposure had a significantly lower risk of breast cancer, and the effect was independent of dietary vitamin D intake. [7]
- Multiple studies have found that women diagnosed with breast cancer in summer or fall — when vitamin D levels are at their peak — have better survival than those diagnosed in winter or spring.
The Biological Plausibility
Breast epithelial cells express the vitamin D receptor and the local activation enzyme (CYP27B1). Calcitriol, acting on breast tissue:
- Downregulates estrogen receptor expression, reducing the proliferative signal of estrogen — the primary driver of hormone-receptor-positive breast cancers
- Induces cell cycle arrest and apoptosis in breast cancer cell lines
- Reduces aromatase activity in the breast, lowering local estrogen production
The link between sunlight, vitamin D, and breast cancer is biologically coherent, epidemiologically consistent, and mechanistically detailed. It is no longer a hypothesis awaiting proof. It is an established relationship awaiting translation into public health messaging.
Prostate Cancer: The Nuanced Relationship
Prostate cancer presents the most nuanced picture — and the one that best illustrates why the sunlight-cancer connection is not a simple “more sun, less cancer” formula.
The Incidence Puzzle
Early studies examining prostate cancer incidence (the rate of new diagnoses) and vitamin D levels produced mixed results. Some found an inverse association. Others found no relationship. A few even suggested a U-shaped curve, with both very low and very high vitamin D levels associated with higher risk.
This created confusion. But as the evidence matured, a clearer picture emerged — one that makes biological sense.
The Mortality Distinction
What separates the prostate cancer literature is the consistent finding that sunlight and vitamin D status are powerfully protective against aggressive, advanced, and fatal prostate cancer, even if the relationship with low-grade, indolent disease is weak or absent.
- A 2012 study in the Journal of the National Cancer Institute found that men with the highest serum vitamin D levels had a 57% lower risk of lethal prostate cancer compared to those with the lowest.
- The Health Professionals Follow-Up Study found that higher predicted vitamin D levels were associated with a significantly lower risk of metastatic and fatal prostate cancer, but not with total prostate cancer incidence.
- A history of non-melanoma skin cancer — a marker of sun exposure — is associated with a lower risk of dying from prostate cancer.
Why This Makes Biological Sense
The prostate gland, like the colon and breast, expresses the vitamin D receptor. Calcitriol in the prostate:
- Inhibits cell proliferation
- Promotes differentiation
- Reduces invasion potential
But the key insight is that calcitriol may not prevent the initiation of prostate cancer — the initial DNA mutations that start a tumor. Instead, it may prevent the progression of that tumor from an indolent, clinically insignificant state to an aggressive, invasive, lethal one.
This is the distinction between getting a small cluster of abnormal cells that never threatens your life, and getting a cancer that spreads to your bones and kills you. Most men over 60 have small, indolent prostate cancers detectable at autopsy — cancers they never knew about and did not die from. What matters is whether those small cancers progress.
Vitamin D appears to be one of the factors that keeps them contained.
A Generation Ago: The Disappearing Indolent Disease
There is a clinical anecdote that captures this biology better than any statistic.
About thirty years ago, it was common for medical school professors to tell their students something half-joking but entirely serious: “If I ever had to choose a cancer, I would choose prostate cancer.”
The reasoning was simple. Prostate cancer, in that era, was widely regarded as a slow-growing, often indolent disease that elderly men frequently died with rather than from. A man diagnosed with prostate cancer at seventy was more likely to die of a heart attack or a stroke than from his prostate tumor. The teaching was that you monitored it, you did not panic, and in many cases, you did not even treat it aggressively.
That characterization has changed. Today, prostate cancer is still often indolent, but the proportion of men presenting with aggressive, advanced, and fatal disease has risen. The question is why.
Many factors have shifted over three decades — PSA screening, diagnostic practices, dietary changes, an aging population. But one factor that has changed dramatically and in parallel is population-wide sun exposure.
Thirty years ago, people spent more time outdoors. Office jobs were less ubiquitous. Screen time was minimal. Sunscreen use, while growing, was not the blanket recommendation it is today. Vitamin D deficiency, while not measured routinely, was almost certainly less prevalent.
Could part of the shift in prostate cancer behavior — from a mostly benign disease to one with a higher proportion of aggressive cases — be related to the simultaneous, population-wide decline in sun exposure and vitamin D status?
The epidemiological evidence is suggestive but not definitive. The biological evidence — the presence of vitamin D receptors in prostate tissue, the anti-proliferative and pro-differentiation effects of calcitriol, the inhibition of invasion and metastasis — is strong. The temporal correlation is real.
It would be an oversimplification to claim that less sun is the sole cause of more aggressive prostate cancer. But it would be equally oversimplified to ignore the possibility that it is a contributing factor — one that is entirely modifiable.
The practical implication remains: sun exposure may not prevent a man from ever developing a prostate cancer cell, but it may prevent that cell from becoming a death sentence. And thirty years ago, when men spent more time outdoors, that may have been exactly what was happening.
Non-Hodgkin Lymphoma: The Immune Surveillance Hypothesis
Non-Hodgkin lymphoma (NHL) provides a different kind of evidence — one that points toward a mechanism beyond vitamin D alone.
The InterLymph Consortium
The International Lymphoma Epidemiology Consortium (InterLymph) pooled data from 20 case-control studies across multiple countries, including over 8,000 NHL cases and 10,000 controls. The findings, published in the International Journal of Cancer, were striking: [3]
- Higher recreational sun exposure was associated with a 30-40% lower risk of developing NHL.
- The protective effect was consistent across lymphoma subtypes.
- The association was independent of known confounders.
Why These Points Beyond Vitamin D
Lymphocytes — the cells that become malignant in lymphoma — do express the vitamin D receptor, and vitamin D does have immunomodulatory effects. But the magnitude and consistency of the NHL-sunlight association have led researchers to propose an additional mechanism: direct ultraviolet radiation (UVR)-mediated immune modulation in the skin.
The skin is not just a physical barrier. It is the body’s largest immune organ. It contains a dense network of antigen-presenting cells (Langerhans cells), T-lymphocytes, and other immune sentinels that constantly sample the external environment.
When UVR hits the skin, it does not just make vitamin D. It directly alters the behavior of these immune cells. It can:
- Induce regulatory T-cells (Tregs) that dampen inappropriate immune responses
- Suppress autoreactive lymphocytes that might otherwise proliferate unchecked
- Modulate the cytokine milieu, shifting the balance away from chronic inflammatory states
The hypothesis — still being tested but strongly suggested by epidemiological data — is that regular, moderate UVR exposure to the skin maintains normal immune surveillance and prevents dysregulated lymphocyte proliferation that leads to lymphoma.
In this framework, lack of UVR is not just a vitamin D deficiency. It is an immune deficiency — the loss of a normal tonic signal that keeps the lymphoid system appropriately regulated.
This is the same mechanism that explains why sun exposure is associated with a lower risk of autoimmune diseases like multiple sclerosis and type 1 diabetes — conditions we will explore in a later article. The skin-immune axis is real, light-dependent, and cannot be replaced by a pill.
The Swedish Women Revisited
We opened this series with a paradox: Swedish women who got more sun developed more skin cancer but lived longer.
The cardiovascular benefits explored in Article 2 accounted for a large part of that survival gap. The metabolic benefits, explored in Article 3, explained another.
But the cancer data adds a further dimension.
The sun avoiders in the Swedish study were not only dying more from heart attacks and metabolic diseases. They were also likely developing and dying from more internal cancers — colon, breast, perhaps aggressive prostate cancers in the men of the cohort, perhaps lymphomas.
The skin cancers that increased in the sun-exposed group were, as we established, overwhelmingly the “easy” ones: BCCs and SCCs that are cured with a minor procedure, and thin melanomas on the extremities with excellent prognoses.
The internal cancers that sunlight may prevent are, in stark contrast, among the most lethal malignancies in medicine. Colon cancer that metastasizes to the liver. Breast cancer that spreads to the bone and brain. Aggressive prostate cancer that infiltrates the spine. These are not “cut it out and move on” cancers. They are the cancers that kill.
The arithmetic of risk is not symmetrical. A modest increase in highly curable skin cancers versus a substantial decrease in lethal internal cancers is a trade-off that, for most people, favors sun exposure. Not reckless, burning, blistering exposure. But regular, moderate, non-burning exposure — the kind the body evolved with.
The Mechanism Summary
| Cancer Type | Strength of Evidence | Proposed Mechanism |
|---|---|---|
| Colon | Strongest; consistent latitude gradient, multiple large cohorts, meta-analyses | Vitamin D/calcitriol → suppresses Wnt/β-catenin, promotes differentiation, reduces inflammation |
| Breast | Strong; meta-analyses show up to 50% risk reduction with high vitamin D | Calcitriol → downregulates estrogen signaling, induces apoptosis, reduces local estrogen production |
| Prostate | Moderate for incidence; strong for aggressive/fatal disease | Calcitriol → prevents progression from indolent to lethal; inhibits invasion and metastasis |
| Non-Hodgkin Lymphoma | Consistent; pooled analysis shows 30-40% risk reduction | Vitamin D immunomodulation + direct UVR skin-immune axis → maintains lymphocyte regulation |
Looking Ahead
If sunlight protects the heart, improves metabolism, and reduces the risk of lethal internal cancers, the case for total sun avoidance becomes difficult to defend.
But there is one more major domain to explore: the bones.
Osteoporosis and hip fractures are among the most devastating and costly conditions of aging. A hip fracture in an elderly person carries a one-year mortality rate of 20-30% — comparable to many cancers. And the evidence linking sunlight to fracture prevention is, in some ways, the oldest and most established of all.
Yet even here, modern megatrials have revealed a paradox: vitamin D pills do not prevent fractures in the general population. Only sunlight — or combined calcium and vitamin D in the deficient — seems to work.
Why a pill cannot replace the sun, and what this means for the skeleton, is the subject of the next article.
Key Takeaways
- The sun causes skin cancer, but it appears to protect against four major internal cancers — colon, breast, prostate, and non-Hodgkin lymphoma — that are collectively far more lethal.
- The mechanism is primarily calcitriol, the active hormonal form of vitamin D, which acts as a master regulator of cell differentiation, proliferation, apoptosis, and angiogenesis in tissues throughout the body.
- Colon cancer shows the strongest inverse association with sun exposure and vitamin D levels, with studies showing up to 40% risk reduction in those with the highest levels.
- Breast cancer risk is up to 50% lower in women with high vitamin D levels, and the mechanism involves downregulation of estrogen signaling in breast tissue.
- Sunlight may not prevent prostate cancer from starting, but it powerfully protects against aggressive and fatal disease — the distinction between an indolent tumor and a lethal one.
- Non-Hodgkin lymphoma risk is 30-40% lower with high sun exposure, and the mechanism likely involves direct UVR-mediated immune modulation in the skin, beyond vitamin D alone.
- The skin is the body’s largest immune organ — UVR directly regulates immune cell behavior, and lack of this regulation may increase lymphoma and autoimmune disease risk.
- The risk-benefit calculus is not symmetrical: sun exposure modestly increases curable skin cancers while substantially decreasing lethal internal cancers.
Don’t Get Sick!
About Dr. Jesse Santiano, MD
Dr. Santiano is a retired internist and emergency physician with extensive clinical experience in metabolic health, cardiovascular prevention, and lifestyle medicine. He reviews all medical content on this site to ensure accuracy, clarity, and safe application for readers. This article is for educational purposes and is not a substitute for personal medical care.
💡 Support This Work
Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.
🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!
Follow me on Facebook, Gab, Twitter (formerly known as X), Instagram, and Telegram.
Articles about benzimidazoles and cancers
- Mebendazole: Repurposing Benzimidazoles As A Powerful New Weapon Against Cancer
- Fenbendazole Warning: Lethal Liver Toxicity With Acetaminophen
- SJS/TEN: Hidden Dangers Of Metronidazole & Mebendazole Combined
- Mebendazole: A New Hope for Adrenocortical Cancer
- Mebendazole Saves Man From Deadly Colon Cancer When Chemo Fails
- When Science Meets Courage: One Man’s Path To Remission
- Fighting Colon Cancer With Albendazole: A Potent Breakthrough You Need To Know
- Mebendazole: A Bold Breakthrough In Brain Metastasis Battle
- Breakthrough Treatment: How Mebendazole Boosts Radiation Therapy For TNBC
- Outsmarting Cancer: How Mebendazole Offers Hope For Brain Tumors
- Mebendazole And Cisplatin: A Hopeful Combination For Ovarian Cancer
- New Lifesaver: How Benzimidazole Targets Drug-Resistant Metastatic Prostate Cancer
- Mebendazole’s Power: A New Weapon Against Aggressive Breast Cancer
References:
[1] Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? International Journal of Epidemiology. 1980;9(3):227-231. doi:10.1093/ije/9.3.227
[2] Kim Y, Je Y. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Breast Cancer Research and Treatment. 2014;145(2):485-495. doi:10.1007/s10549-014-2955-3
[3] Kricker A, Armstrong BK, Hughes AM, et al. Personal sun exposure and risk of non-Hodgkin lymphoma: a pooled analysis from the InterLymph Consortium. International Journal of Cancer. 2008;122(1):144-154. doi:10.1002/ijc.23003
[4] Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. Journal of the National Cancer Institute. 2006;98(7):451-459. doi:10.1093/jnci/djj101
[5] McCullough ML, Zoltick ES, Weinstein SJ, et al. Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts. Journal of the National Cancer Institute. 2019;111(2):158-169. doi:10.1093/jnci/djy087
[6] Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiology, Biomarkers & Prevention. 2005;14(8):1991-1997. doi:10.1158/1055-9965.EPI-04-0722
[7] Anderson LN, Cotterchio M, Kirsh VA, Knight JA. Ultraviolet sunlight exposure during adolescence and adulthood and breast cancer risk: a population-based case-control study among Ontario women. Cancer Causes & Control. 2011;22(8):1183-1192. doi:10.1007/s10552-011-9796-6
Disclaimer:
This article is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions based on the TyG Index or other biomarkers.
© 2018 – 2026 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment
As an Amazon Associate, I earn from qualifying purchases
Discover more from Don't Get Sick!
Subscribe to get the latest posts sent to your email.